Not Signed In -
Testosterone Transdermal |
Androderm; Testoderm; Testoderm TTS |
Clinical Trial: Comparing Smoking Treatment Programs for Lighter Smokers - 1
This study is currently recruiting patients.
Purpose
The purpose of this study is to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications used in conjunction with two levels of smokers.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Tobacco Use Disorder | Drug: nicotine transdermal system | Phase II |
MedlinePlus related topics: Smoking
Study Type: Interventional
Study Design: Treatment, Uncontrolled, Parallel Assignment
Official Title: Comparing Smoking Treatment Programs for Lighter Smokers
Expected Total Enrollment: 270
Study start: September 2003; Expected completion: June 2008
Eligibility
Ages Eligible for Study: 18 Years - 75 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Light smokers (6-15 cigarettes per day
Inclusion Criteria:
Mentally and physically stable, non-pregnant, light smokers (6-15 cigarettes per day
Exclusion Criteria:
Please contact site for more information
Location and Contact Information
Pennsylvania
University of Pennsylvania, Philadelphia, Pennsylvania, 19104 6178, United States; Recruiting
Peter W Gariti, Ph.D., Principal Investigator, University of Pennsylvania
More Information
Record last reviewed: September 2003
Last Updated: February 24, 2005
Record first received: July 1, 2004
ClinicalTrials.gov Identifier: NCT00086411
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
